|
PHARMABIZ.COM
Indoco Remedies launches new division, Indoco CND
Our Bureau, Mumbai
Thursday, April 05, 2012, 14:00 Hrs [IST]
As the Indian pharmaceutical industry has been witnessing phenomenal growth in diabetes
and cardiovascular segments, Indoco Remedies has launched a new division for care in
cardiology and diabetology (Indoco CND) in Mumbai.
Under the leadership of Aditi Kare Panandikar, managing director of Indoco and B Rajendra
Kumar, vice president -Sales & Marketing, Indoco, rigorous training programmes are being
conducted for a specialized and highly skilled field force, ensuring Indoco CND’s success.
This division will be spearheaded by Atul Joshi, general manager, Marketing & Sales,
Indoco. He will be backed by 245 trained field force. The blueprint for promotion and
growth strategy has been discussed with the team and the division is now set to
consistently add significant value to the company’s sales growth.
Indoco Remedies Limited, a pharmaceutical company with sales turnover of Rs. 600 crore,
too identified few products for such chronic diseases and have been present in this
Super Specialty segment with successful brand launches like ‘Glychek’ and ‘Telmicheck’.
To reinforce its position in this segment, Indoco recently launched a new division viz.
(Care in Cardiology and Diabetology). Besides Indoco CND, Indoco Remedies Limited has a
strong presence in the Indian Domestic Market through its seven divisions viz. Indoco,
Spade, Warren, Spera, Excel, Extend and Eterna, operating in different therapeutic
segments.
Indoco Remedies Limited is a fast growing, fully integrated, research oriented
pharmaceutical company with a Global presence. Indoco manufactures a wide range of
pharmaceutical products in various therapeutic segments for Indian and International
markets. It generates more than 50 million prescriptions annually from over 125000
doctors in India.
|